Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the Breast
Clinical Breast Cancer · 2025
DOI: 10.1016/j.clbc.2024.08.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Breast Cancer, 2025. Verfasst von Chiara M Ciniselli und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Data Science, Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Hauptthemen laut MEDLINE: Erb-b2 Receptor Tyrosine Kinases, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Data Science, Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
- Department of Epidemiology and Data Science, Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: paolo.verderio@istitutotumori.mi.it.
- Department of Epidemiology and Data Science, Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
- Analytical Epidemiology and Health Impact Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
- Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; University of Milan, Milano, Italy.
- Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Zitieren
APA
Ciniselli, C. M., Verderio, P., Baili, P., Sant, M., Pizzamiglio, S., Duroni, V., de Braud, F. G., Folli, S., Scaperrotta, G., De Santis, M. C., Apolone, G., De Marco, C., Vingiani, A., Cappelletti, V., Pruneri, G., & Di Cosimo, S. (2025). Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the Breast. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2024.08.002
Vancouver
Ciniselli CM, Verderio P, Baili P, Sant M, Pizzamiglio S, Duroni V, et al. Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the Breast. Clinical Breast Cancer. 2025. doi:10.1016/j.clbc.2024.08.002
BibTeX
@article{Ciniselli2025,
author = {Ciniselli, Chiara M and Verderio, Paolo and Baili, Paolo and Sant, Milena and Pizzamiglio, Sara and Duroni, Valeria and de Braud, Filippo G and Folli, Secondo and Scaperrotta, Gianfranco and De Santis, Maria C and Apolone, Giovanni and De Marco, Cinzia and Vingiani, Andrea and Cappelletti, Vera and Pruneri, Giancarlo and Di Cosimo, Serena},
title = {Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the Breast},
journal = {Clinical Breast Cancer},
year = {2025},
doi = {10.1016/j.clbc.2024.08.002}
}
EUVIMED